Skip to content

Clinical trials

Terminated Rheumatic Diseases trials in the United States

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Rheumatic Diseases Status: Terminated Country / region: United States Clear all

11 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20022
20101
20111
20162
20171
20181
20191
20222

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Terminated11

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Novartis Pharmaceuticals2
Eli Lilly and Company1
National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)1
National Institutes of Health Clinical Center (CC)1
Oregon Health and Science University1
Pfizer1
Smith & Nephew, Inc.1
Tonix Pharmaceuticals, Inc.1
University of California, San Francisco1
VA Office of Research and Development1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Rheumatic Diseases11
Musculoskeletal Diseases6
Arthritis5
Joint Diseases5
Autoimmune Diseases4
Arthritis, Rheumatoid3
Connective Tissue Diseases3
Immune System Diseases3
Osteoarthritis3
Lupus Erythematosus, Systemic2

Trials

Showing 1 to 11 of 11. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.